Public Company

Natco Pharma receives the cancer drug boost

Natco Pharma touched a high of Rs 134 and a low of Rs 124. The stock finally ended with a 5.2% at Rs 129. Around 2.96 lakh shares were traded on the BSE as against the two-week average trade of 1.06 lakh shares. __________________________________________________ UCO Bank seeks shareholders" nod for fund raising Negative view on state-run oil cos: Fitch Jan cement sales in high double-digit The government stayed the Drug Controller of India order suspending the drug for not passing the test measuring endotoxin levels. Albupax is a nanatechnology-based drug. It consists of paclitaxel in an Albumin-bound nanoparticle form and is used in the treatment of breast cancer.

Add your comment:

Name:
Site address:	http://
Your message:
Enter today\\\\'s date, 2 digits (spam protection):